Filing Details
- Accession Number:
- 0001179110-21-004603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-26 16:14:36
- Reporting Period:
- 2021-04-23
- Accepted Time:
- 2021-04-26 16:14:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1724521 | Arcus Biosciences Inc. | RCUS | Pharmaceutical Preparations (2834) | 473898435 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1730229 | William Grossman | C/O Arcus Biosciences, Inc. 3928 Point Eden Way Hayward CA 94545 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-04-23 | 4,133 | $31.37 | 6,717 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold in a private transaction to Dr. Yasunori Kaneko, a director of Arcus Biosciences, Inc. The shares, representing approximately 1.6% of the total shares either owned or that may be acquired by Dr. Grossman upon exercise of options that are vested and exercisable, were sold by Dr. Grossman as part of his tax plan.